In summary, while the prechallenge immunogenicity data demonstrated high magnitude effector antibody functions previously tied to some HIV vaccine efficacy, our results imply that Env-specific ADCC and ADCP responses induced by this candidate vaccine regimen were not sufficient to prevent infection with oral tier 2 SHIV1157(QNE)Y375H in infant RM. This evidence concerns the gene ERVW-1 and infection.